[go: up one dir, main page]

PL343482A1 - Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph - Google Patents

Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph

Info

Publication number
PL343482A1
PL343482A1 PL99343482A PL34348299A PL343482A1 PL 343482 A1 PL343482 A1 PL 343482A1 PL 99343482 A PL99343482 A PL 99343482A PL 34348299 A PL34348299 A PL 34348299A PL 343482 A1 PL343482 A1 PL 343482A1
Authority
PL
Poland
Prior art keywords
carnitine
nadh
nadph
alkanoyl
composition
Prior art date
Application number
PL99343482A
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of PL343482A1 publication Critical patent/PL343482A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Nutrition Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL99343482A 1998-04-17 1999-04-14 Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph PL343482A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT98RM000238A IT1299161B1 (en) 1998-04-17 1998-04-17 COMPOSITION INCLUDING L-CARNITINE OR AN ALCANOYL L-CARNITINE AND NADH AND / OR NADPH

Publications (1)

Publication Number Publication Date
PL343482A1 true PL343482A1 (en) 2001-08-27

Family

ID=11405812

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99343482A PL343482A1 (en) 1998-04-17 1999-04-14 Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph

Country Status (17)

Country Link
EP (1) EP1071424A1 (en)
JP (1) JP2002512191A (en)
KR (1) KR20010042765A (en)
CN (1) CN1299283A (en)
AU (1) AU750645B2 (en)
BR (1) BR9909712A (en)
CA (1) CA2328331A1 (en)
EE (1) EE200000601A (en)
HU (1) HUP0101914A3 (en)
IL (1) IL139014A0 (en)
IS (1) IS5663A (en)
IT (1) IT1299161B1 (en)
NO (1) NO20005128L (en)
PL (1) PL343482A1 (en)
SK (1) SK15442000A3 (en)
TR (1) TR200002894T2 (en)
WO (1) WO1999053921A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8252309B2 (en) 2000-04-04 2012-08-28 Sigma-Tau Industrie Farmaceutiche Riunite Spa Dietary supplement energy-providing to skeletal muscles
DE10326822A1 (en) * 2003-06-11 2005-01-05 Herzpharma Vita-Check Diagnosegeräte GmbH Dietary supplement, e.g. for increasing general performance, concentration and endurance, comprises NADH, L-carnitine, coenzyme Q10, L-carnosine, succinic acid, ascorbic acid and bioflavonoids
AU2007353211B2 (en) * 2007-05-11 2013-08-29 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Gel useful for the delivery of cosmetic active ingredients
AU2010286348A1 (en) * 2009-08-31 2012-03-22 University Of South Australia Methods for diagnosis and treatment of chronic fatigue syndrome
CN104306390A (en) * 2014-10-23 2015-01-28 苏州人本药业有限公司 Application of reduced coenzyme II
CN104840479A (en) * 2015-02-17 2015-08-19 苏州人本药业有限公司 Application of NADPH in preparation of drugs used for treating heart diseases
ES2786774B2 (en) * 2017-12-22 2022-03-04 Bontac Bio Eng Shenzhen Co Ltd Composition for NADH coenzyme compound, preparation and application thereof.
HUE056844T2 (en) 2018-04-20 2022-03-28 Pacotrade Ag Device for crushing deep-frozen foodstuffs provided in block form
CN109105702A (en) * 2018-08-30 2019-01-01 泓博元生命科技（深圳）有限公司 A kind of preparation method of composition containing NADH, application and energy extender
CN109170907A (en) * 2018-08-30 2019-01-11 泓博元生命科技（深圳）有限公司 A kind of preparation method of composition containing NMN, application and sports drink
AU2019357838A1 (en) * 2018-10-10 2021-04-15 So Ngor Sally LEUNG Health product composition for supplementing deficiency, preparation method therefor and application thereof
CN117958433A (en) * 2024-03-22 2024-05-03 四川新渔新美健康科技有限公司 Caffeine-free anti-fatigue functional composition and beverage

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054698A (en) * 1964-12-04
US5292538A (en) * 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
DE4335454A1 (en) * 1993-10-19 1995-04-20 Schleicher Peter Geriatric medical composition
JPH09110708A (en) * 1995-08-11 1997-04-28 Taisho Pharmaceut Co Ltd Nutritional tonic crude drug combination preparation
JPH0959161A (en) * 1995-08-23 1997-03-04 Taisho Pharmaceut Co Ltd Fatigue improving composition
IT1277953B1 (en) * 1995-12-21 1997-11-12 Sigma Tau Ind Farmaceuti PHARMACEUTICAL COMPOSITION CONTAINING L-CARNITINE OR AN ALCANOYL L-CARNITINE AND A 3-OMEGA SERIES POLYUNSATURED ACID USEFUL
IT1283951B1 (en) * 1996-03-15 1998-05-07 Mendes Srl USE OF ACETYL L-CARNITINE OR ITS PHARMACOLOGICALLY ACCEPTABLE SALTS FOR THERAPEUTIC TREATMENT OR PROPHYLAXIS OF
US5712259A (en) * 1996-04-22 1998-01-27 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
JPH10175856A (en) * 1996-10-14 1998-06-30 Taisho Pharmaceut Co Ltd Fatigue improver

Also Published As

Publication number Publication date
BR9909712A (en) 2000-12-26
TR200002894T2 (en) 2001-01-22
HUP0101914A3 (en) 2002-12-28
ITRM980238A0 (en) 1998-04-17
CA2328331A1 (en) 1999-10-28
NO20005128D0 (en) 2000-10-12
SK15442000A3 (en) 2001-06-11
HUP0101914A2 (en) 2002-03-28
CN1299283A (en) 2001-06-13
JP2002512191A (en) 2002-04-23
IL139014A0 (en) 2001-11-25
EE200000601A (en) 2002-04-15
AU750645B2 (en) 2002-07-25
IS5663A (en) 2000-10-13
ITRM980238A1 (en) 1999-10-17
EP1071424A1 (en) 2001-01-31
NO20005128L (en) 2000-12-18
AU3442899A (en) 1999-11-08
IT1299161B1 (en) 2000-02-29
WO1999053921A1 (en) 1999-10-28
KR20010042765A (en) 2001-05-25

Similar Documents

Publication Publication Date Title
HU9903361D0 (en) Filter-device with collecting-vessel and with heating-device
SG79263A1 (en) Adhesive composition and adhesive sheet
IL183948A (en) Peg-urate oxidase conjugates and use thereof
AP2001002286A0 (en) Compound and its use
AU2052800A (en) Metal and wood bat
IL128869A0 (en) Pyrozolopyrimidines and pyrazolotriazines
GB9813271D0 (en) Composition and use
HU9900536D0 (en) Mg alloy member and its use
PL347357A1 (en) Novel composition and use
AU1037900A (en) Magnetic bearing and its use
SG87813A1 (en) Curable epoxide composition and its use
PL343482A1 (en) Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph
AU9293998A (en) Wrinkle and malodour reducing composition
HUP0103636A3 (en) 2-methyl-thieno-benzodiazepine formulation and its use
EP1056455A4 (en) Epimorphian compound and its use
ZA976791B (en) Composition comprising mupirocin and chlohexidine
AU9301998A (en) Composition and methods using galectin-1
GB9803232D0 (en) Compound composition and use
HUP0101602A3 (en) Fertility improving composition and application thereof
IL120481A0 (en) Combined enzyme composition and its use
GB9805172D0 (en) Composition and use
SG77680A1 (en) An epoxy-resin composition and use thereof
GB9722392D0 (en) Composition and use
AU3098300A (en) Pad4 compositions and methods therefor
GB9826250D0 (en) Novel composition and use

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)